Grants, awards and scholarships, proudly funded by ERF, allow the SNMMI to keep its commitment to supporting the next generation of researchers and advancing molecular imaging and therapy. This support of early career pilot grants fills a funding void for young innovators who need funding to demonstrate the feasibility of their novel ideas before they can apply for larger government grants from the National Institutes of Health, National Science Foundation or other sources.
For a complete listing of all SNMMI awards, visit their website.
Applications are now closed.
The Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs) is designed to help a basic or clinical scientist in the early stages of his/her career conduct novel and innovative research that may be leveraged to lead to further funding from other foundations, corporations or government agencies.
The grant will provide $100,000 for a two-year award. Second year funding will be contingent on satisfactory first-year progress reports. Funds will be directed to the sponsoring institution. Funds may be used to support the salary of the applicant, research costs, and/or travel. Indirect expenses are capped at 5%.
Applications for this grant are currently closed and will open again in winter 2019.
Learn More and Apply:
The 2020 ERF/NETRF Nuclear Medicine Pilot Research Grant in NETs is sponsored by the Neuroendocrine Tumor Research Foundation with the generous support of the Margie and Robert E. Petersen Foundation. Written progress reports will be required at six-month intervals, outlining all progress to date. At the conclusion of the award period, the recipient must provide ERF with a final written report of the project performed during the award period and budget reconciliation. The investigator selected for the grant will be expected to attend the annual NETRF Research Symposium throughout the project and immediately thereafter to present findings. Grant funds shall be used to cover travel costs to the Symposium. Additionally, a brief annual update for the five years following the research will be required including:
●Investigator’s future clinical and research plans, especially regarding the field of neuroendocrine tumors and molecular imaging;
●Listing of reference citations for all articles or presentations arising from the recipient’s research project;
●Listing of all subsequent funding that has been secured for the research project from other agencies and entities.
●Basic or clinical scientists with an advanced degree, such as MD, PhD, or equivalent are eligible.
●The research may be done in any country.
●Awardee must hold a full-time faculty or equivalent position in an educational institution when the award starts.
●Applicant must be no more than five years post training (most recent training; training includes residency, MD/PhD training, professional school, graduate school, post doc, or fellowship).
●Applicant must not have served as the principal investigator of a peer-reviewed grant for more than $100,000 in a single calendar year.
●Preference will be given to individuals who have demonstrated great potential for a research career in the field of nuclear medicine/molecular imaging and whose research focuses on translational in vivo studies that include radionuclide imaging or therapy for NETs.
To Apply/Submission Requirements:
There is no application form to complete. All packaged applications must have the following components in the order listed. Incomplete applications will not be considered.
●Title page: Applicant Name, Project Title, Institution
●Principal investigator’s current curriculum vitae
●Research Plan (no more than 3 pages) containing the following elements:
-Background and Significance
-Preliminary Data (if available)
●Personal Statement by the Candidate (1-2 pages): the applicant should include description of any past research projects, evidence of interest in neuroendocrine tumors*, and description of how the project will contribute to the future development of the candidate as a clinician and/or investigator in the field of neuroendocrine tumors.
*Neuroendocrine tumors can occur throughout the body, but primary sites include the gastrointestinal tract, pancreas, rectum, lungs, and appendix. The majority of neuroendocrine tumors can be divided into two classes: carcinoid and pancreatic neuroendocrine tumors. Pheochromocytoma is a rare form of neuroendocrine tumor.
●NIH Biosketch of the Applicant (2-page maximum)
●Letter of Institutional Support (1 page)
●Proposed Budget: The funds can be used to support the salary of the applicant, research costs and/or travel.
●Please note: No grantee may receive more than one research grant from ERF in any one year. Likewise, no other grant request will be considered until a satisfactory summary of an earlier grant is received.
Evaluation and Selection Criteria:
●The proposal is highly relevant to advancing molecular imaging.
●The work is completely original and innovative.
●The proposal reflects sound methodology that is likely to prove the hypothesis.
●The protocol is based on good, scientific reasoning.
●The applicant has the knowledge/skills, resources to successfully conclude this project.
●The applicant has the support of his/her institution.
There is no formal application form. Applicants should provide every item listed under the "Submission Requirements" in the order listed. Only complete packages should be submitted via email by 5:00 p.m. E.D.T. U.S. on January 28, 2019. Incomplete packages will not be considered and ERF is not responsible for ensuring packages are complete.
Electronically submit cover letter with all documentation listed under "submission requirements" to: firstname.lastname@example.org Email subject: ‘NETS Pilot Research Grant Material Submission - LAST NAME’
Funding of this award is subject to the approval and availability of grant funds appropriated to ERF. Therefore, ERF reserves the right to alter the number of investigator awards, terms and allowances.
Applications are now closed.
The Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF), through a bequest from the estates of Benedict Cassen and Mary Wiley Cassen, is offering grant support for a junior scientist faculty member to recruit a post-doctoral to support research in the field of nuclear medicine and molecular imaging. The grant is intended to provide an early-career scientist with mentoring experience and the opportunity to develop preliminary data for federal or other competitive research support. The grant will provide support for the postdoctoral fellow to carry out the research under the supervision of the junior faculty member, with the assistance of a senior faculty member or principal investigator. Selection of a postdoctoral fellow from relevant disciplines outside nuclear medicine and molecular imaging is encouraged but not required. Overall administrative and research guidance for the postdoctoral fellow is to be provided by a senior mentor in the same institution.
The Postdoctoral Mentoring Award provides up to two years of research support. The amount of the award is $50,000 per year, payable to the applicant’s institution, which is to be used for salary support (including benefits) of the postdoctoral fellow. The postdoc candidate does not need to be nominated or identified at the time of application and can recruited after the award is made. The award may be renewed for a second year, subject to ERF review and approval of first-year progress.
The ERF Cassen Review Committee will review proposals. The Committee is composed of internationally prominent scientists with expertise in education, research and technology in nuclear medicine and molecular imaging. Review criteria includes the applicant’s academic record, career development plan and potential to develop into an independent researcher in nuclear medicine and molecular imaging, research plan, mentor and mentorship plan, and institutional research environment.
Each recipient of an ERF grant, as a condition of acceptance of the award, agrees to the following:
The Benedict Cassen Prize is awarded in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science. The prize award is $25,000 and is only offered every other year (even years).